Source: Virtual Congress 2021 – Interstitial lung disease around the world



Rating:

Share or cite this content

Citations should be made in the following way:
M. Norestani (Copenhagen, Denmark). Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis. 3755

Member's Comments

No comment yet.

Related content which might interest you: Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Impact of depression on patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019 Epidemiology of Idiopathic Pulmonary Fibrosis in Australia Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary Source: Guideline 2015 Year: 2015 Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Predictors of Progression in Patients with Pulmonary Sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Postoperative Pulmonary Complications in Bronchial Asthma/Chronic Obstructive Pulmonary Disease/Non-Pulmonary Disease Patients Source: International Congress 2018 – Functional assessment of COPD Year: 2018